BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 345499)

  • 41. Carcinosarcoma of the Breast: An Aggressive Subtype of Metaplastic Cancer. Report of a Rare Case in a Young BRCA-1 Mutated Woman.
    Ghilli M; Mariniello DM; Fanelli G; Cascione F; Fontana A; Cristaudo A; Cilotti A; Caligo AM; Manca G; Colizzi L; Naccarato AG; Roncella M
    Clin Breast Cancer; 2017 Feb; 17(1):e31-e35. PubMed ID: 27697421
    [No Abstract]   [Full Text] [Related]  

  • 42. The effect of internal mammary lymph node biopsy on the therapeutic decision and survival of patients with breast cancer.
    Ozmen V; Ozcinar B; Bozdogan A; Eralp Y; Yavuz E; Dincer M
    Eur J Surg Oncol; 2015 Oct; 41(10):1368-72. PubMed ID: 26210653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nevus cells in axillary lymph nodes from radical mastectomy specimens.
    Andreola S; Clemente C
    Pathol Res Pract; 1985 May; 179(6):616-8. PubMed ID: 4022839
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical impact of extracapsular extension of axillary lymph node metastases in breast cancer].
    Zhang B; Cao WF; Zhao HM; Song YQ; Ning LS; Niu Y; Hao XS; Cao XC
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):790-4. PubMed ID: 20021837
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Benefits of axillary radiotherapy unclear in women with early stage breast cancer undergoing conservative breast surgery without axillary dissection.
    Sanuki-Fujimoto N
    Cancer Treat Rev; 2005 Oct; 31(6):496-500. PubMed ID: 16199127
    [No Abstract]   [Full Text] [Related]  

  • 46. Computerized tomography of breast cancer and regional lymph nodes.
    Hahn H; Hoeffken W
    Diagn Imaging Clin Med; 1985; 54(3-4):165-9. PubMed ID: 3849366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The significance of lymph nodes detected by xeroradiography in cancer of the breast.
    Rayter Z; Williams J; Gazet JC
    Clin Oncol; 1981 Mar; 7(1):39-43. PubMed ID: 7214762
    [No Abstract]   [Full Text] [Related]  

  • 48. [Parasternal lymphoscintigraphy in mastocarcinoma, its diagnostic value and significance for prognosis (author's transl)].
    Pescia R; Heinzel F
    Rontgenblatter; 1978 Jun; 31(6):337-41. PubMed ID: 675064
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Breast cancer: can axillary lymph node dissection be avoided?
    Barry M; Kell MR
    Eur J Surg Oncol; 2012 Jan; 38(1):6-7. PubMed ID: 22014429
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast.
    Veronesi U; Saccozzi R; Del Vecchio M; Banfi A; Clemente C; De Lena M; Gallus G; Greco M; Luini A; Marubini E; Muscolino G; Rilke F; Salvadori B; Zecchini A; Zucali R
    N Engl J Med; 1981 Jul; 305(1):6-11. PubMed ID: 7015141
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The number of axillary lymph nodes involved with metastatic breast cancer does not affect outcome as long as all disease is confined to the sentinel lymph nodes.
    Jakub JW; Bryant K; Huebner M; Hoskin T; Boughey JC; Reynolds C; Degnim AC
    Ann Surg Oncol; 2011 Jan; 18(1):86-93. PubMed ID: 20593241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High rate of solitary sentinel node metastases identification by fluorescence-guided lymphatic imaging in breast cancer.
    Hirche C; Mohr Z; Kneif S; Murawa D; Hünerbein M
    J Surg Oncol; 2012 Feb; 105(2):162-6. PubMed ID: 21882198
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Importance of controlling the regional draining lymph nodes in breast cancer.
    Carter SK
    Cancer Clin Trials; 1978; 1(3):227-33. PubMed ID: 391428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Benefits of locoregional treatment.
    Lawrence GA; Crawford J
    J Clin Oncol; 2003 Dec; 21(24):4660-1; author reply 4661-2. PubMed ID: 14673067
    [No Abstract]   [Full Text] [Related]  

  • 55. [Lymph drainage from the breast to the parasternal lymph nodes].
    Kett K; Szilágyi K; Schmidt L
    Orv Hetil; 1993 Aug; 134(35):1913-5. PubMed ID: 8361746
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coexistence of metastatic breast carcinoma and primary tuberculosis in axillary lymph nodes: a report of a rare case.
    Pujani M; Khan S; Hassan MJ; Jetley S; Raina PK
    Breast Dis; 2015; 35(3):195-8. PubMed ID: 26406543
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lymphscintigraphies of the internal mammary ganglion chain: our experience.
    Del Castillo RA; Kuschnir E; Figueras S; Ferreyra R
    Eur J Gynaecol Oncol; 1986; 7(2):82-7. PubMed ID: 3720790
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sounding board. Breast-cancer management: alternatives to radical mastectomy.
    Fisher B
    N Engl J Med; 1979 Aug; 301(6):326-8. PubMed ID: 450022
    [No Abstract]   [Full Text] [Related]  

  • 59. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?
    Tausch C; Baege A; Dietrich D; Vergin I; Heuer H; Heusler RH; Rageth C
    Eur J Surg Oncol; 2013 Aug; 39(8):880-6. PubMed ID: 23735162
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer.
    Voogd AC; de Boer R; van der Sangen MJ; Roumen RM; Rutten HJ; Coebergh JW
    Eur J Surg Oncol; 2001 Apr; 27(3):250-5. PubMed ID: 11373100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.